董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Benjamin Wolin President and Chief Executive Officer, Director 44 未披露 未持股 2020-03-03
Mark J. Manoff Director 69 未披露 未持股 2020-03-03
Edward M. McNamara Director 61 未披露 未持股 2020-03-03
Philip A. Laskawy Chairman of the Board and Director 83 未披露 未持股 2020-03-03
Steven Paladino Director 67 未披露 未持股 2020-03-03
David E. Shaw Director 73 未披露 未持股 2020-03-03
Ravi Sachdev Director 48 未披露 未持股 2020-03-03
Deborah G. Ellinger Director 66 未披露 未持股 2020-03-03
Sandra L. Helton Director 75 未披露 未持股 2020-03-03
Benjamin Wolin President and Chief Executive Officer, Director 44 未披露 未持股 2020-03-03

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Benjamin Wolin President and Chief Executive Officer, Director 44 未披露 未持股 2020-03-03
Erin Powers Brennan Senior Vice President, General Counsel and Secretary 49 未披露 未持股 2020-03-03
Michael Ellis Executive Vice President, President of Europe and North America 61 未披露 未持股 2020-03-03
David Hinton Executive Vice President, President of APAC & Emerging Markets 59 未披露 未持股 2020-03-03
Timothy Ludlow Senior Vice President and Chief Transformation Officer 54 未披露 未持股 2020-03-03
Anthony Providenti Senior Vice President, Corporate Development 52 未披露 未持股 2020-03-03
Georgina Wraight Executive Vice President, President of Global Technology Solutions 45 未披露 未持股 2020-03-03
Dustin K. Finer -- Chief People Officer and Chief Administrative Officer 50 未披露 未持股 2020-03-03
Stuart B. Gleichenhaus -- Interim Chief Financial Officer 62 未披露 未持股 2020-03-03
Laura J. Phillips -- Vice President, Global Controller and Chief Accounting Officer 50 未披露 未持股 2020-03-03
Benjamin Wolin President and Chief Executive Officer, Director 44 未披露 未持股 2020-03-03

董事简历

中英对照 |  中文 |  英文
Benjamin Wolin

Benjamin Wolin自2015年10月起一直担任董事。Wolin先生自2002年1月起是Everyday Health, Inc. (数字保健和健康解决方案的一家领先供应商,NYSE: EVDY)的联合创始人、首席执行官和董事会的成员。1999年9月至2001年12月,Wolin先生担任Beliefnet, Inc.(一家宗教和精神信息的在线供应商)生产兼技术的副总裁。此前,Wolin先生任职 Web Producer for Tribune Interactive, Inc.(一家多媒体公司)和在互动的公司担任几个咨询职位。


Benjamin Wolin has been a director since October 2015 and the independent Lead Director since February 2017. Mr. Wolin was the co-founder, Chief Executive Officer, and a member of the board of directors of Everyday Health, Inc. NYSE: EVDY, a leading provider of digital health and wellness solutions, from January 2002 until its sale to a subsidiary of j2 Global, Inc. in December 2016. From September 1999 until December 2001 Mr. Wolin served as Vice President of Production and Technology for Beliefnet, Inc., an online provider of religious and spiritual information. Previously, Mr. Wolin served as Web Producer for Tribune Interactive, Inc., a multimedia corporation, and held several consulting positions with interactive companies.
Benjamin Wolin自2015年10月起一直担任董事。Wolin先生自2002年1月起是Everyday Health, Inc. (数字保健和健康解决方案的一家领先供应商,NYSE: EVDY)的联合创始人、首席执行官和董事会的成员。1999年9月至2001年12月,Wolin先生担任Beliefnet, Inc.(一家宗教和精神信息的在线供应商)生产兼技术的副总裁。此前,Wolin先生任职 Web Producer for Tribune Interactive, Inc.(一家多媒体公司)和在互动的公司担任几个咨询职位。
Benjamin Wolin has been a director since October 2015 and the independent Lead Director since February 2017. Mr. Wolin was the co-founder, Chief Executive Officer, and a member of the board of directors of Everyday Health, Inc. NYSE: EVDY, a leading provider of digital health and wellness solutions, from January 2002 until its sale to a subsidiary of j2 Global, Inc. in December 2016. From September 1999 until December 2001 Mr. Wolin served as Vice President of Production and Technology for Beliefnet, Inc., an online provider of religious and spiritual information. Previously, Mr. Wolin served as Web Producer for Tribune Interactive, Inc., a multimedia corporation, and held several consulting positions with interactive companies.
Mark J. Manoff

MarkJ.Manoff于2019年2月被任命为我们的董事会成员。Manoff先生自1990年起担任安永的合伙人,直至2017年退休担任美洲副主席。在EY任职期间,Manoff先生担任多个职位,包括纽约办事处管理合伙人和东北地区管理合伙人。他还创立并领导了EY Center for Board Matters。Manoff先生是Metropolitan New York(一家青年发展组织)第一TEE的董事会成员。此外,Manoff先生担任纽约市Roundrough Theatre的董事会成员约10年至2018年5月,并在此期间担任其审计委员会主席。Manoff先生是马里兰大学RobertH.Smith商学院(University of Maryland&8217;s School of Business)的顾问委员会成员(之前担任主席),在那里他获得了会计学学士学位。


Mark J. Manoff was appointed to our Board in February 2019 in connection with the Transactions. Mr. Manoff was a partner of EY from 1990 until his retirement as Americas Vice Chair in 2017. During his time with EY, Mr. Manoff held various positions including New York Office Managing Partner and Northeast Region Managing Partner. He also founded and led the EY Center for Board Matters. Mr. Manoff is a member of the board of directors of The First Tee of Metropolitan New York, a youth development organization. In addition, Mr. Manoff was a member of the board of directors for Roundabout Theatre in New York City for approximately 10 years through May 2018 and was chair of its audit committee during that period. Mr. Manoff serves on the Advisory Board (previously serving as Chair) at the University of Maryland’s Robert H. Smith School of Business, where he received his B.S. in Accounting.
MarkJ.Manoff于2019年2月被任命为我们的董事会成员。Manoff先生自1990年起担任安永的合伙人,直至2017年退休担任美洲副主席。在EY任职期间,Manoff先生担任多个职位,包括纽约办事处管理合伙人和东北地区管理合伙人。他还创立并领导了EY Center for Board Matters。Manoff先生是Metropolitan New York(一家青年发展组织)第一TEE的董事会成员。此外,Manoff先生担任纽约市Roundrough Theatre的董事会成员约10年至2018年5月,并在此期间担任其审计委员会主席。Manoff先生是马里兰大学RobertH.Smith商学院(University of Maryland&8217;s School of Business)的顾问委员会成员(之前担任主席),在那里他获得了会计学学士学位。
Mark J. Manoff was appointed to our Board in February 2019 in connection with the Transactions. Mr. Manoff was a partner of EY from 1990 until his retirement as Americas Vice Chair in 2017. During his time with EY, Mr. Manoff held various positions including New York Office Managing Partner and Northeast Region Managing Partner. He also founded and led the EY Center for Board Matters. Mr. Manoff is a member of the board of directors of The First Tee of Metropolitan New York, a youth development organization. In addition, Mr. Manoff was a member of the board of directors for Roundabout Theatre in New York City for approximately 10 years through May 2018 and was chair of its audit committee during that period. Mr. Manoff serves on the Advisory Board (previously serving as Chair) at the University of Maryland’s Robert H. Smith School of Business, where he received his B.S. in Accounting.
Edward M. McNamara

EdwardM.McNamara于2019年2月被任命为我们的董事会成员。在此任命之前,McNamara先生从2011年6月开始担任Vets First Choice Board的成员。他是TeamLaunch,LLC(风险建设公司,他于2013年共同创立)的总裁。他是由TeamLaunch,LLC创立的奢侈品公司RCW Inc.DBA M.Gemi的首席财务官和董事。McNamara先生担任或曾经担任秘书,财务主管或董事的其他TeamLaunch私人投资组合公司包括Launch Kids,Inc.(2015年12月至2017年12月);Follain Launch,Inc.(2016年5月至今);Seed Leaf,LLC(2016年12月至今)。创立TeamLaunch之前,McNamara从2011年到2013年担任General Catalyst Partners常驻高管,专注于消费者增长机会。在此之前,他曾于2005年至2011年担任Retail Convergence Inc.(DBA rue La La)(一家私人销售公司)及其前身SmartBargains Inc.的首席财务官。McNamara从1996年到2004年在Cendant Corporation的两个运营业务部门担任多个高管职位,包括首席财务官、首席运营官、总裁和临时首席执行官,这两个部门包括WrightExpress,Inc.和Cendant的旅游分销部门。McNamara从1999年到2001年担任Wright Express Financial Services,Inc(一家银行公司)董事长。McNamara从1993年到1996年担任Abex Inc.(一家航空制造公司)及其关联公司Fisher Scientific Corp.(一家生物技术公司)多个会计、财务和行政职位。McNamara先生从1986年到1993年在普华永道(Pricewaterhouse)开始了他的职业生涯,这是一家会计师事务所,在审计和咨询小组专注于上市公司审计和并购,离开时担任审计实践的经理。McNamara先生还自2014年起担任化妆品公司Counter Brands,LLC(DBA Beauty Counter)的董事会成员和正式顾问。McNamara先生拥有普罗维登斯学院(Providence College)学士学位。


Edward M. McNamara was appointed to our Board in February 2019 in connection with the Transactions. Prior to such appointment, Mr. McNamara served from June 2011 as a member of the Vets First Choice Board. He is the President of TeamLaunch, LLC, a venture-building company, which he cofounded in 2013. He is the Chief Financial Officer and director of RCW Inc. dba M.Gemi, a luxury product company founded by TeamLaunch, LLC. Other TeamLaunch private portfolio companies where Mr. McNamara serves or has served as Secretary, Treasurer or director include Launch Kids, Inc. from December 2015 to December 2017; Follain Launch, Inc. from May 2016 to present; and Seed Leaf, LLC from December 2016 to present. Prior to founding TeamLaunch, Mr. McNamara served as an executive in residence at General Catalyst Partners from 2011 to 2013 and focused on consumer growth opportunities. Prior to that, he served as the Chief Financial Officer of Retail Convergence Inc. (dba Rue La La), a private-sale business and its predecessor Smartbargains Inc., from 2005 to 2011. Mr. McNamara served in a number of executive roles, including Chief Financial Officer, Chief Operating Officer, President and Interim Chief Executive Officer, at two operating businesses of Cendant Corporation from 1996 to 2004 including Wright Express, Inc. and Cendant’s Travel Distribution Division. Mr. McNamara was Chairman of the Board of Wright Express Financial Services, Inc, a banking company, from 1999 to 2001. Mr. McNamara served in a number of accounting, finance and administrative positions for Abex Inc., an aerospace manufacturing company, and its related company Fisher Scientific Corp., a biotechnology company, from 1993 to 1996. Mr. McNamara started his career with PriceWaterhouse, an accounting firm, from 1986 to 1993 in the audit and advisory group focused on public company audits and mergers and acquisitions, leaving as a manager in the audit practice. Mr. McNamara has also served as a member of the board of directors of, and a formal advisor to, Counter Brands, LLC (dba Beauty Counter), a cosmetics company, since 2014. Mr. McNamara holds a B.S. from Providence College.
EdwardM.McNamara于2019年2月被任命为我们的董事会成员。在此任命之前,McNamara先生从2011年6月开始担任Vets First Choice Board的成员。他是TeamLaunch,LLC(风险建设公司,他于2013年共同创立)的总裁。他是由TeamLaunch,LLC创立的奢侈品公司RCW Inc.DBA M.Gemi的首席财务官和董事。McNamara先生担任或曾经担任秘书,财务主管或董事的其他TeamLaunch私人投资组合公司包括Launch Kids,Inc.(2015年12月至2017年12月);Follain Launch,Inc.(2016年5月至今);Seed Leaf,LLC(2016年12月至今)。创立TeamLaunch之前,McNamara从2011年到2013年担任General Catalyst Partners常驻高管,专注于消费者增长机会。在此之前,他曾于2005年至2011年担任Retail Convergence Inc.(DBA rue La La)(一家私人销售公司)及其前身SmartBargains Inc.的首席财务官。McNamara从1996年到2004年在Cendant Corporation的两个运营业务部门担任多个高管职位,包括首席财务官、首席运营官、总裁和临时首席执行官,这两个部门包括WrightExpress,Inc.和Cendant的旅游分销部门。McNamara从1999年到2001年担任Wright Express Financial Services,Inc(一家银行公司)董事长。McNamara从1993年到1996年担任Abex Inc.(一家航空制造公司)及其关联公司Fisher Scientific Corp.(一家生物技术公司)多个会计、财务和行政职位。McNamara先生从1986年到1993年在普华永道(Pricewaterhouse)开始了他的职业生涯,这是一家会计师事务所,在审计和咨询小组专注于上市公司审计和并购,离开时担任审计实践的经理。McNamara先生还自2014年起担任化妆品公司Counter Brands,LLC(DBA Beauty Counter)的董事会成员和正式顾问。McNamara先生拥有普罗维登斯学院(Providence College)学士学位。
Edward M. McNamara was appointed to our Board in February 2019 in connection with the Transactions. Prior to such appointment, Mr. McNamara served from June 2011 as a member of the Vets First Choice Board. He is the President of TeamLaunch, LLC, a venture-building company, which he cofounded in 2013. He is the Chief Financial Officer and director of RCW Inc. dba M.Gemi, a luxury product company founded by TeamLaunch, LLC. Other TeamLaunch private portfolio companies where Mr. McNamara serves or has served as Secretary, Treasurer or director include Launch Kids, Inc. from December 2015 to December 2017; Follain Launch, Inc. from May 2016 to present; and Seed Leaf, LLC from December 2016 to present. Prior to founding TeamLaunch, Mr. McNamara served as an executive in residence at General Catalyst Partners from 2011 to 2013 and focused on consumer growth opportunities. Prior to that, he served as the Chief Financial Officer of Retail Convergence Inc. (dba Rue La La), a private-sale business and its predecessor Smartbargains Inc., from 2005 to 2011. Mr. McNamara served in a number of executive roles, including Chief Financial Officer, Chief Operating Officer, President and Interim Chief Executive Officer, at two operating businesses of Cendant Corporation from 1996 to 2004 including Wright Express, Inc. and Cendant’s Travel Distribution Division. Mr. McNamara was Chairman of the Board of Wright Express Financial Services, Inc, a banking company, from 1999 to 2001. Mr. McNamara served in a number of accounting, finance and administrative positions for Abex Inc., an aerospace manufacturing company, and its related company Fisher Scientific Corp., a biotechnology company, from 1993 to 1996. Mr. McNamara started his career with PriceWaterhouse, an accounting firm, from 1986 to 1993 in the audit and advisory group focused on public company audits and mergers and acquisitions, leaving as a manager in the audit practice. Mr. McNamara has also served as a member of the board of directors of, and a formal advisor to, Counter Brands, LLC (dba Beauty Counter), a cosmetics company, since 2014. Mr. McNamara holds a B.S. from Providence College.
Philip A. Laskawy

Philip A. Laskawy自2008年7月担任Lazard有限责任公司和Lazard集团董事。Laskawy先生自1994年到他2001年退休一直担任安永会计师事务所董事会主席以及首席执行官,他在这样一家提供专业服务的公司工作了40年。Laskawy先生从2006年到2007年担任国际会计准则委员会主席,同时为1999蓝丝带委员会委员,该委员会旨在提升企业审计委员会效力。Laskawy先生于2008年9月在房利美公司委员会成立之际被任命为房利美公司董事会主席,他预计在2014年3月31日退休,届时他将会在公司任职超过5年。Laskawy先生是Loews集团和Henry Schein股份有限公司董事会成员。Laskawy先生先前担任通用汽车公司董事,并一直担任此职务到2013年6月。


Philip A. Laskawy,has served as the Lead Director at Henry Schein, Inc. since 2012, where he provides strategic oversight and guidance to the company, leveraging his extensive experience in corporate governance and leadership.From 1994 to 2001, he held the position of Chairman and Chief Executive Officer (CEO) of EY LLP. During this time, he was instrumental in shaping the firm's strategy, expanding its global reach, and enhancing its service offerings to clients across various sectors. His governance and leadership helped EY navigate the challenges of the accounting industry during a transformative era.Prior to becoming CEO, Philip served as Vice Chairman and Managing Partner for the New York Region from 1985 to 1994, as well as a Member of the Management Committee. He was also the Managing Partner of the New York Office from 1981 to 2001, where he managed critical operations and client relationships, contributing to the firm's growth and success in the region.Philip is a Certified Public Accountant (CPA), showcasing his expertise in financial practices and regulatory matters. He earned a Bachelor of Arts (B.A.) degree from the Wharton School of Business at the University of Pennsylvania, with a focus on Economics.
Philip A. Laskawy自2008年7月担任Lazard有限责任公司和Lazard集团董事。Laskawy先生自1994年到他2001年退休一直担任安永会计师事务所董事会主席以及首席执行官,他在这样一家提供专业服务的公司工作了40年。Laskawy先生从2006年到2007年担任国际会计准则委员会主席,同时为1999蓝丝带委员会委员,该委员会旨在提升企业审计委员会效力。Laskawy先生于2008年9月在房利美公司委员会成立之际被任命为房利美公司董事会主席,他预计在2014年3月31日退休,届时他将会在公司任职超过5年。Laskawy先生是Loews集团和Henry Schein股份有限公司董事会成员。Laskawy先生先前担任通用汽车公司董事,并一直担任此职务到2013年6月。
Philip A. Laskawy,has served as the Lead Director at Henry Schein, Inc. since 2012, where he provides strategic oversight and guidance to the company, leveraging his extensive experience in corporate governance and leadership.From 1994 to 2001, he held the position of Chairman and Chief Executive Officer (CEO) of EY LLP. During this time, he was instrumental in shaping the firm's strategy, expanding its global reach, and enhancing its service offerings to clients across various sectors. His governance and leadership helped EY navigate the challenges of the accounting industry during a transformative era.Prior to becoming CEO, Philip served as Vice Chairman and Managing Partner for the New York Region from 1985 to 1994, as well as a Member of the Management Committee. He was also the Managing Partner of the New York Office from 1981 to 2001, where he managed critical operations and client relationships, contributing to the firm's growth and success in the region.Philip is a Certified Public Accountant (CPA), showcasing his expertise in financial practices and regulatory matters. He earned a Bachelor of Arts (B.A.) degree from the Wharton School of Business at the University of Pennsylvania, with a focus on Economics.
Steven Paladino

Steven Paladino于2000年起担任Henry Schein, Inc.(一家为医疗保健专业人员提供解决方案的公司)的执行副总裁兼首席财务官Steven Paladino,至2022年4月退休。在此之前,Paladino先生曾在Henry Schein, Inc.担任其他重要职务,包括1993年至2000年担任高级副总裁兼首席财务官,1990年至1992年担任副总裁兼财务主管,1987年至1990年担任公司财务总监。在加入Henry Schein, Inc.之前,Paladino先生曾担任注册会计师七年,最近一次是在BDO Seidman LLP(现称为BDO USA,LLP)国际会计师事务所工作。


Steven Paladino,served as Executive Vice President and Chief Financial Officer of Henry Schein, Inc., a solutions company for healthcare professionals, from 2000 until his retirement in April 2022. Prior to that, Mr. Paladino served in other key roles with Henry Schein, Inc., including Senior Vice President and Chief Financial Officer from 1993 to 2000, Vice President and Treasurer from 1990 to 1992, and Corporate Controller from 1987 to 1990. Before joining Henry Schein, Inc., Mr. Paladino was employed as a Certified Public Accountant for seven years, most recently with the international accounting firm of BDO Seidman LLP (now known as BDO USA, LLP).
Steven Paladino于2000年起担任Henry Schein, Inc.(一家为医疗保健专业人员提供解决方案的公司)的执行副总裁兼首席财务官Steven Paladino,至2022年4月退休。在此之前,Paladino先生曾在Henry Schein, Inc.担任其他重要职务,包括1993年至2000年担任高级副总裁兼首席财务官,1990年至1992年担任副总裁兼财务主管,1987年至1990年担任公司财务总监。在加入Henry Schein, Inc.之前,Paladino先生曾担任注册会计师七年,最近一次是在BDO Seidman LLP(现称为BDO USA,LLP)国际会计师事务所工作。
Steven Paladino,served as Executive Vice President and Chief Financial Officer of Henry Schein, Inc., a solutions company for healthcare professionals, from 2000 until his retirement in April 2022. Prior to that, Mr. Paladino served in other key roles with Henry Schein, Inc., including Senior Vice President and Chief Financial Officer from 1993 to 2000, Vice President and Treasurer from 1990 to 1992, and Corporate Controller from 1987 to 1990. Before joining Henry Schein, Inc., Mr. Paladino was employed as a Certified Public Accountant for seven years, most recently with the international accounting firm of BDO Seidman LLP (now known as BDO USA, LLP).
David E. Shaw

David E. Shaw,自2004年起,他担任董事。他是Black Point Group LLC(一个私营投资合伙公司)的董事总经理。自2004年至2007年,他曾是Vienrock(一个风险投资公司)的合伙人,以及New Mountain Capital, LLC 的顾问,在这段时间,他还担任 National Medical Health Card Systems, Inc.(一个药品福利管理公司)的董事。自2008年至2009年,他担任 Ikaria Holdings, Inc.(一个制药公司)的执行主席;2007年至2008年,他担任其首席执行官。他还任职于Sapphire Energy Inc., Direct Vet Marketing Inc., Itaconix Inc., the National Parks Foundation, the Sargasso Sea Alliance 和 the American Association for Advancement of Science AAAS(在该公司他还是财务主管)的董事会。他是IDEXX Laboratories Inc.(一个医疗技术公司)的创始人和前任首席执行官;他还在其他生命技术公司很活跃。他持有 the University of New Hampshire的学士学位,以及the University of Maine的工商管理学硕士学位。


David E. Shaw was appointed to our Board in February 2019 in connection with the Transactions and serves as the Chairman of our Board. Mr. Shaw was the co-founder of Vets First Choice and served as chair of Vets First Choice Board from May 2010 until such appointment. Mr. Shaw is currently Managing Partner of Black Point Group, a private investment partnership. He founded and has led Black Point Group since January 2003. Mr. Shaw also founded IDEXX Laboratories, Inc., or IDEXX, a developer of products and services for the companion animal and veterinary industry. He served as Chief Executive Officer and board chair of IDEXX from 1984 to 2002. He has served on the board of directors of Itaconix PLC, a private company that creates functional polymers, from 2011 to present, and Modern Meadow, Inc., a private company that manufactures an environmentally friendly leather alternative, from 2014 to present. Mr. Shaw previously served on the board of directors of Ironwood Pharmaceuticals, Inc., a pharmaceutical company, from 2004 to 2014. Additionally, Mr. Shaw has served on the faculty of Harvard's John F. Kennedy School of Government as well as on the non-profit boards of The Jackson Laboratory, the American Association for the Advancement of Science AAAS, the National Park Foundation, and the Aspen Institute's Aspen High Seas Initiative. He began his career as a strategy consultant to consumer product, food, and agribusiness companies. Mr. Shaw earned his B.A. from the University of New Hampshire and MBA from the University of Southern Maine. He has been awarded honorary degrees by Colby College, Bates College, Maine College of Art, and the University of Southern Maine. It is for these reasons that it was determined he should serve as chair of our Board.
David E. Shaw,自2004年起,他担任董事。他是Black Point Group LLC(一个私营投资合伙公司)的董事总经理。自2004年至2007年,他曾是Vienrock(一个风险投资公司)的合伙人,以及New Mountain Capital, LLC 的顾问,在这段时间,他还担任 National Medical Health Card Systems, Inc.(一个药品福利管理公司)的董事。自2008年至2009年,他担任 Ikaria Holdings, Inc.(一个制药公司)的执行主席;2007年至2008年,他担任其首席执行官。他还任职于Sapphire Energy Inc., Direct Vet Marketing Inc., Itaconix Inc., the National Parks Foundation, the Sargasso Sea Alliance 和 the American Association for Advancement of Science AAAS(在该公司他还是财务主管)的董事会。他是IDEXX Laboratories Inc.(一个医疗技术公司)的创始人和前任首席执行官;他还在其他生命技术公司很活跃。他持有 the University of New Hampshire的学士学位,以及the University of Maine的工商管理学硕士学位。
David E. Shaw was appointed to our Board in February 2019 in connection with the Transactions and serves as the Chairman of our Board. Mr. Shaw was the co-founder of Vets First Choice and served as chair of Vets First Choice Board from May 2010 until such appointment. Mr. Shaw is currently Managing Partner of Black Point Group, a private investment partnership. He founded and has led Black Point Group since January 2003. Mr. Shaw also founded IDEXX Laboratories, Inc., or IDEXX, a developer of products and services for the companion animal and veterinary industry. He served as Chief Executive Officer and board chair of IDEXX from 1984 to 2002. He has served on the board of directors of Itaconix PLC, a private company that creates functional polymers, from 2011 to present, and Modern Meadow, Inc., a private company that manufactures an environmentally friendly leather alternative, from 2014 to present. Mr. Shaw previously served on the board of directors of Ironwood Pharmaceuticals, Inc., a pharmaceutical company, from 2004 to 2014. Additionally, Mr. Shaw has served on the faculty of Harvard's John F. Kennedy School of Government as well as on the non-profit boards of The Jackson Laboratory, the American Association for the Advancement of Science AAAS, the National Park Foundation, and the Aspen Institute's Aspen High Seas Initiative. He began his career as a strategy consultant to consumer product, food, and agribusiness companies. Mr. Shaw earned his B.A. from the University of New Hampshire and MBA from the University of Southern Maine. He has been awarded honorary degrees by Colby College, Bates College, Maine College of Art, and the University of Southern Maine. It is for these reasons that it was determined he should serve as chair of our Board.
Ravi Sachdev

Ravi Sachdev,自2019年8月起担任公司董事,担任提名/公司治理委员会成员,并于2008年9月至2025年3月担任审计委员会成员。自2015年6月起担任私募股权公司Clayton Dubilier & Rice, LLC的合伙人,他专注于医疗保健行业。早些时候,萨赫杰夫曾在几家投资银行工作。2010年11月至2015年6月,他曾担任J.P. Morgan的董事总经理兼医疗保健服务联席主管。在此之前,他曾担任Deutsche Bank Securities, Inc.的董事总经理(2009年1月至2010年11月),德意志银行董事(2007年1月至2009年1月)。在2006年加入Deutsche Bank担任副总裁之前,1998年至2006年,他曾担任Peter J. Solomon Company(一家投资银行精品,专门从事医疗保健行业的并购)的副总裁。Sachdev先生拥有财务和财务分析Steven Madden, Ltd.的知识,以衡量企业绩效。


Ravi Sachdev,has served as a director of the Company as a member of the Nominating/Corporate Governance Committee since August 2019 and as a member of the Audit Committee from September 2008 until March 2025. As a Partner of the private equity firm Clayton Dubilier & Rice, LLC since June 2015, Mr. Sachdev focuses on the healthcare sector. Earlier, Mr. Sachdev worked at several investment banks. He was a Managing Director and Co- Head of Healthcare Services at J.P. Morgan from November 2010 until June 2015 and prior to that held the positions of Managing Director at Deutsche Bank Securities, Inc. from January 2009 until November 2010 and Director at Deutsche Bank from January 2007 until January 2009. Prior to joining Deutsche Bank in 2006 as a Vice President, Mr. Sachdev served as a Vice President at Peter J. Solomon Company, an investment banking boutique, specializing in mergers and acquisitions in the healthcare sector, from 1998 to 2006. Mr. Sachdev possesses knowledge of finance and the financial analytics Steven Madden, Ltd. ed to measure business performance.
Ravi Sachdev,自2019年8月起担任公司董事,担任提名/公司治理委员会成员,并于2008年9月至2025年3月担任审计委员会成员。自2015年6月起担任私募股权公司Clayton Dubilier & Rice, LLC的合伙人,他专注于医疗保健行业。早些时候,萨赫杰夫曾在几家投资银行工作。2010年11月至2015年6月,他曾担任J.P. Morgan的董事总经理兼医疗保健服务联席主管。在此之前,他曾担任Deutsche Bank Securities, Inc.的董事总经理(2009年1月至2010年11月),德意志银行董事(2007年1月至2009年1月)。在2006年加入Deutsche Bank担任副总裁之前,1998年至2006年,他曾担任Peter J. Solomon Company(一家投资银行精品,专门从事医疗保健行业的并购)的副总裁。Sachdev先生拥有财务和财务分析Steven Madden, Ltd.的知识,以衡量企业绩效。
Ravi Sachdev,has served as a director of the Company as a member of the Nominating/Corporate Governance Committee since August 2019 and as a member of the Audit Committee from September 2008 until March 2025. As a Partner of the private equity firm Clayton Dubilier & Rice, LLC since June 2015, Mr. Sachdev focuses on the healthcare sector. Earlier, Mr. Sachdev worked at several investment banks. He was a Managing Director and Co- Head of Healthcare Services at J.P. Morgan from November 2010 until June 2015 and prior to that held the positions of Managing Director at Deutsche Bank Securities, Inc. from January 2009 until November 2010 and Director at Deutsche Bank from January 2007 until January 2009. Prior to joining Deutsche Bank in 2006 as a Vice President, Mr. Sachdev served as a Vice President at Peter J. Solomon Company, an investment banking boutique, specializing in mergers and acquisitions in the healthcare sector, from 1998 to 2006. Mr. Sachdev possesses knowledge of finance and the financial analytics Steven Madden, Ltd. ed to measure business performance.
Deborah G. Ellinger

Deborah G. Ellinger,现为咨询投资公司Ellinger Enterprises的总裁;她从2004年起担任该职,同时还在其它公司担任顾问、行政的职务。2009年,她担任Wellness Pet Food的总裁;2004-2008,在该公司担任过其它一些职务,其中包括首席执行官。2001-2003,她担任CVS Pharmacy的执行副总裁,这是美国最大的药物卫生保健公司。她还一直是Staples的副总裁、The Boston Consulting Group的合伙人;在The Boston Consulting Group开启职业生涯。2007年起,她担任National Life Group的董事,这是一个金融服务控股公司,旗下拥有人寿保险和资产管理公司;2011年起,担任National Life Group的董事,这是一个民用及军用机器人制造商;2011年起,担任Renew Life Holdings Corporation的董事,这是消费者消化助剂产品制造商。她是伦敦的出庭律师、Inner Temple的成员;在伦敦的University of Cambridge获得法律与数学的硕士、学士学位。她从2010年9月起,担任本公司董事。


Deborah G. Ellinger,Former President or CEO of four private-equity backed companies, and currently a Senior Advisor to Boston Consulting Group since 2018. Ms. Ellinger's past leadership roles include: President and CEO of Ideal Image, a chain of 130 medical spas providing non-surgical cosmetic procedures across the US and Canada, from 2016 until 2018; Chairman and Chief Executive Officer of The Princeton Review, a company which assists students globally in test preparation and tutoring, from 2012 to 2014; President of Restoration Hardware, a luxury home furnishings retailer, from 2008 to 2009; and Chief Executive Officer of Wellness Pet Food, a natural pet-food company, from 2004 to 2008. She has held other senior executive roles at CVS Pharmacy and Staples, and also served as a partner at The Boston Consulting Group.Ms. Ellinger is qualified as a Barrister-at-Law in London, as a member of the Inner Temple. She holds an M.A. and B.A. in Law and Mathematics from the University of Cambridge, England.
Deborah G. Ellinger,现为咨询投资公司Ellinger Enterprises的总裁;她从2004年起担任该职,同时还在其它公司担任顾问、行政的职务。2009年,她担任Wellness Pet Food的总裁;2004-2008,在该公司担任过其它一些职务,其中包括首席执行官。2001-2003,她担任CVS Pharmacy的执行副总裁,这是美国最大的药物卫生保健公司。她还一直是Staples的副总裁、The Boston Consulting Group的合伙人;在The Boston Consulting Group开启职业生涯。2007年起,她担任National Life Group的董事,这是一个金融服务控股公司,旗下拥有人寿保险和资产管理公司;2011年起,担任National Life Group的董事,这是一个民用及军用机器人制造商;2011年起,担任Renew Life Holdings Corporation的董事,这是消费者消化助剂产品制造商。她是伦敦的出庭律师、Inner Temple的成员;在伦敦的University of Cambridge获得法律与数学的硕士、学士学位。她从2010年9月起,担任本公司董事。
Deborah G. Ellinger,Former President or CEO of four private-equity backed companies, and currently a Senior Advisor to Boston Consulting Group since 2018. Ms. Ellinger's past leadership roles include: President and CEO of Ideal Image, a chain of 130 medical spas providing non-surgical cosmetic procedures across the US and Canada, from 2016 until 2018; Chairman and Chief Executive Officer of The Princeton Review, a company which assists students globally in test preparation and tutoring, from 2012 to 2014; President of Restoration Hardware, a luxury home furnishings retailer, from 2008 to 2009; and Chief Executive Officer of Wellness Pet Food, a natural pet-food company, from 2004 to 2008. She has held other senior executive roles at CVS Pharmacy and Staples, and also served as a partner at The Boston Consulting Group.Ms. Ellinger is qualified as a Barrister-at-Law in London, as a member of the Inner Temple. She holds an M.A. and B.A. in Law and Mathematics from the University of Cambridge, England.
Sandra L. Helton

Sandra L. Helton 从1998年到2006年一直担任Telephone and Data Systems, Inc. "TDS"的执行副总裁兼首席财务官。该公司是一个多元化的电信组织,包括美国移动公司(United States Cellular Corporation)。截至2006年12月31日,TDS在36个州有700万客户/服务单位,年收入为45亿美元。Helton女士任职时负责金融、信息技术、战略规划、企业公关和公司秘书。在加入TDS之前,Helton女士在Corning Incorporated工作了26年。在那里她担任工程、战略和财务职位,包括从1991 年到1997年担任高级副总裁兼财务主管。她还从1997年到1998年担任康柏电脑公司(Compaq Computer Corporation )的副总裁和公司财务总监。


Sandra L. Helton,has served as a director of Optinose, Inc. since February 2018. Through May 2022 Ms. Helton served on the Board of Directors of Principal Financial Group (Principal), a global diversified financial institution, where she chaired the Audit Committee and served on Principal's Executive Committee and Finance Committee, which she previously chaired. Prior to the company going private in October 2022, Ms. Helton also served on the Board of Directors of Covetrus, a worldwide animal health business and chaired their Audit Committee and served on their Nominating and Governance Committee. Prior to the acquisition of Lexmark International Inc. in November 2016, she served on their Board of Directors and Finance and Audit Committee. Ms. Helton also served on the board of Covance Inc., a leading global drug development services company, prior to LabCorp acquiring the company in 2015. She chaired the Finance and Audit Committee and served on the Nominating and Governance Committee of Covance. Ms. Helton was Executive Vice President and Chief Financial Officer, and member of the Board of Directors, of Telephone and Data Systems, Inc. (TDS) from 1998 through 2006. Her responsibilities included strategic planning, finance and information systems, among other functions. Ms. Helton also served on the Boards of United States Cellular Corporation and Aerial Corporation, TDS's publicly traded subsidiaries. Before TDS, Ms. Helton was Vice President, Corporate Controller of Compaq Computer Corporation. Prior to Compaq, Ms. Helton held over a dozen increasingly responsible positions during her 26-year tenure with Corning Incorporated. Ms. Helton serves on the Board of Northwestern Memorial Foundation. She previously served on the Board of Northwestern Memorial Health Care, a nationally recognized academic medical center, where she chaired the Audit Committee and was a member of the Executive, Finance and Investment Committees. Ms. Helton holds an S.M. in Finance from Massachusetts Institute of Technology's Sloan School of Management and graduated with a B.S. in Mathematics from the University of Kentucky.
Sandra L. Helton 从1998年到2006年一直担任Telephone and Data Systems, Inc. "TDS"的执行副总裁兼首席财务官。该公司是一个多元化的电信组织,包括美国移动公司(United States Cellular Corporation)。截至2006年12月31日,TDS在36个州有700万客户/服务单位,年收入为45亿美元。Helton女士任职时负责金融、信息技术、战略规划、企业公关和公司秘书。在加入TDS之前,Helton女士在Corning Incorporated工作了26年。在那里她担任工程、战略和财务职位,包括从1991 年到1997年担任高级副总裁兼财务主管。她还从1997年到1998年担任康柏电脑公司(Compaq Computer Corporation )的副总裁和公司财务总监。
Sandra L. Helton,has served as a director of Optinose, Inc. since February 2018. Through May 2022 Ms. Helton served on the Board of Directors of Principal Financial Group (Principal), a global diversified financial institution, where she chaired the Audit Committee and served on Principal's Executive Committee and Finance Committee, which she previously chaired. Prior to the company going private in October 2022, Ms. Helton also served on the Board of Directors of Covetrus, a worldwide animal health business and chaired their Audit Committee and served on their Nominating and Governance Committee. Prior to the acquisition of Lexmark International Inc. in November 2016, she served on their Board of Directors and Finance and Audit Committee. Ms. Helton also served on the board of Covance Inc., a leading global drug development services company, prior to LabCorp acquiring the company in 2015. She chaired the Finance and Audit Committee and served on the Nominating and Governance Committee of Covance. Ms. Helton was Executive Vice President and Chief Financial Officer, and member of the Board of Directors, of Telephone and Data Systems, Inc. (TDS) from 1998 through 2006. Her responsibilities included strategic planning, finance and information systems, among other functions. Ms. Helton also served on the Boards of United States Cellular Corporation and Aerial Corporation, TDS's publicly traded subsidiaries. Before TDS, Ms. Helton was Vice President, Corporate Controller of Compaq Computer Corporation. Prior to Compaq, Ms. Helton held over a dozen increasingly responsible positions during her 26-year tenure with Corning Incorporated. Ms. Helton serves on the Board of Northwestern Memorial Foundation. She previously served on the Board of Northwestern Memorial Health Care, a nationally recognized academic medical center, where she chaired the Audit Committee and was a member of the Executive, Finance and Investment Committees. Ms. Helton holds an S.M. in Finance from Massachusetts Institute of Technology's Sloan School of Management and graduated with a B.S. in Mathematics from the University of Kentucky.
Benjamin Wolin

Benjamin Wolin 2002年1月(公司创立之时)他是我们公司的共同创始人,并担任公司的首席执行官,也是公司董事的成员,1999年9月至2001年12月,他担任Beliefnet公司生产与科技的副总裁,其是一家为宗教和精神信息的在线供应商。此前,他担任互动式论坛网页制作公司的董事,该是一家多媒体公司,并在这家互动式公司担任了咨询职位。他担任了几家私人控股公司董事。他获得了Bowdoin学院历史学士学位。


Benjamin Wolin,Former Chief Executive Officer and Co-founder of Everyday Health, Inc.
Benjamin Wolin 2002年1月(公司创立之时)他是我们公司的共同创始人,并担任公司的首席执行官,也是公司董事的成员,1999年9月至2001年12月,他担任Beliefnet公司生产与科技的副总裁,其是一家为宗教和精神信息的在线供应商。此前,他担任互动式论坛网页制作公司的董事,该是一家多媒体公司,并在这家互动式公司担任了咨询职位。他担任了几家私人控股公司董事。他获得了Bowdoin学院历史学士学位。
Benjamin Wolin,Former Chief Executive Officer and Co-founder of Everyday Health, Inc.

高管简历

中英对照 |  中文 |  英文
Benjamin Wolin

Benjamin Wolin自2015年10月起一直担任董事。Wolin先生自2002年1月起是Everyday Health, Inc. (数字保健和健康解决方案的一家领先供应商,NYSE: EVDY)的联合创始人、首席执行官和董事会的成员。1999年9月至2001年12月,Wolin先生担任Beliefnet, Inc.(一家宗教和精神信息的在线供应商)生产兼技术的副总裁。此前,Wolin先生任职 Web Producer for Tribune Interactive, Inc.(一家多媒体公司)和在互动的公司担任几个咨询职位。


Benjamin Wolin has been a director since October 2015 and the independent Lead Director since February 2017. Mr. Wolin was the co-founder, Chief Executive Officer, and a member of the board of directors of Everyday Health, Inc. NYSE: EVDY, a leading provider of digital health and wellness solutions, from January 2002 until its sale to a subsidiary of j2 Global, Inc. in December 2016. From September 1999 until December 2001 Mr. Wolin served as Vice President of Production and Technology for Beliefnet, Inc., an online provider of religious and spiritual information. Previously, Mr. Wolin served as Web Producer for Tribune Interactive, Inc., a multimedia corporation, and held several consulting positions with interactive companies.
Benjamin Wolin自2015年10月起一直担任董事。Wolin先生自2002年1月起是Everyday Health, Inc. (数字保健和健康解决方案的一家领先供应商,NYSE: EVDY)的联合创始人、首席执行官和董事会的成员。1999年9月至2001年12月,Wolin先生担任Beliefnet, Inc.(一家宗教和精神信息的在线供应商)生产兼技术的副总裁。此前,Wolin先生任职 Web Producer for Tribune Interactive, Inc.(一家多媒体公司)和在互动的公司担任几个咨询职位。
Benjamin Wolin has been a director since October 2015 and the independent Lead Director since February 2017. Mr. Wolin was the co-founder, Chief Executive Officer, and a member of the board of directors of Everyday Health, Inc. NYSE: EVDY, a leading provider of digital health and wellness solutions, from January 2002 until its sale to a subsidiary of j2 Global, Inc. in December 2016. From September 1999 until December 2001 Mr. Wolin served as Vice President of Production and Technology for Beliefnet, Inc., an online provider of religious and spiritual information. Previously, Mr. Wolin served as Web Producer for Tribune Interactive, Inc., a multimedia corporation, and held several consulting positions with interactive companies.
Erin Powers Brennan

Erin Powers Brennan,Vets First Choice的总法律顾问;Morgan,Lewis&Bockius LLP的合伙人。


Erin Powers Brennan,General Counsel of Vets First Choice; Partner at Morgan, Lewis & Bockius LLP.
Erin Powers Brennan,Vets First Choice的总法律顾问;Morgan,Lewis&Bockius LLP的合伙人。
Erin Powers Brennan,General Counsel of Vets First Choice; Partner at Morgan, Lewis & Bockius LLP.
Michael Ellis

Michael Ellis,首席财务官,Vice President总经理,Henry Schein Animal Health欧洲区总裁。


Michael Ellis,Chief Financial Officer, General Manager, Vice President, & President of Europe at Henry Schein Animal Health.
Michael Ellis,首席财务官,Vice President总经理,Henry Schein Animal Health欧洲区总裁。
Michael Ellis,Chief Financial Officer, General Manager, Vice President, & President of Europe at Henry Schein Animal Health.
David Hinton

David Hinton,Henry Schein的澳大利亚和新西兰Vice President兼董事总经理;Henry Schein Animal Health的英国、爱尔兰和法国Vice President兼董事总经理。


David Hinton,Vice President & Managing Director of Australia and New Zealand at Henry Schein; Vice President & Managing Director of U.K., Ireland, and France at Henry Schein Animal Health.
David Hinton,Henry Schein的澳大利亚和新西兰Vice President兼董事总经理;Henry Schein Animal Health的英国、爱尔兰和法国Vice President兼董事总经理。
David Hinton,Vice President & Managing Director of Australia and New Zealand at Henry Schein; Vice President & Managing Director of U.K., Ireland, and France at Henry Schein Animal Health.
Timothy Ludlow

Timothy Ludlow,首席财务官,Vets First Choice的首席整合官和转型官;Pine State Trading Company的首席财务官;C&S Wholesale Grocers的高级副总裁和财务主管。


Timothy Ludlow,Chief Financial Officer, Chief Integration Officer & Transformation Officer at Vets First Choice; Chief Financial Officer at Pine State Trading Company; Senior Vice President & Treasurer at C&S Wholesale Grocers.
Timothy Ludlow,首席财务官,Vets First Choice的首席整合官和转型官;Pine State Trading Company的首席财务官;C&S Wholesale Grocers的高级副总裁和财务主管。
Timothy Ludlow,Chief Financial Officer, Chief Integration Officer & Transformation Officer at Vets First Choice; Chief Financial Officer at Pine State Trading Company; Senior Vice President & Treasurer at C&S Wholesale Grocers.
Anthony Providenti

Anthony Providenti,Henry Schein企业业务发展Vice President;Henry Schein Animal Health战略与发展Vice President。


Anthony Providenti,Vice President of Corporate Business Development at Henry Schein; Vice President of Strategy & Development at Henry Schein Animal Health.
Anthony Providenti,Henry Schein企业业务发展Vice President;Henry Schein Animal Health战略与发展Vice President。
Anthony Providenti,Vice President of Corporate Business Development at Henry Schein; Vice President of Strategy & Development at Henry Schein Animal Health.
Georgina Wraight

Georgina Wraight,Vets First Choice的总裁兼首席运营官;Rockport Group的首席运营官;首席财务官Highline Group的首席运营官;以及Ernst&Young,Walt Disney和BBC的其他财务职位。


Georgina Wraight,President & Chief Operating Officer at Vets First Choice; Chief Operating Officer The Rockport Group; Chief Operating Office, Chief Financial Officer Highline Group; and other financial Positions at Ernst & Young, Walt Disney, and the BBC.
Georgina Wraight,Vets First Choice的总裁兼首席运营官;Rockport Group的首席运营官;首席财务官Highline Group的首席运营官;以及Ernst&Young,Walt Disney和BBC的其他财务职位。
Georgina Wraight,President & Chief Operating Officer at Vets First Choice; Chief Operating Officer The Rockport Group; Chief Operating Office, Chief Financial Officer Highline Group; and other financial Positions at Ernst & Young, Walt Disney, and the BBC.
Dustin K. Finer

DustinK.Finer,TiVo/Rovi的首席行政和内部运营官;MySpace的运营主管。


Dustin K. Finer,Chief Administrative & Internal Operations Officer at TiVo/Rovi; Chief of Operations at MySpace.
DustinK.Finer,TiVo/Rovi的首席行政和内部运营官;MySpace的运营主管。
Dustin K. Finer,Chief Administrative & Internal Operations Officer at TiVo/Rovi; Chief of Operations at MySpace.
Stuart B. Gleichenhaus

StuartB.Gleichenhaus,FTIConsulting,Inc.公司的高级常务董事;合并整合和分拆业务的联合领导&首席财务官解决方案业务办公室的领导;Angus Chemicals、AgroFresh、ATW和Carestream Dental的临时首席财务官。


Stuart B. Gleichenhaus,Senior Managing Director at FTI Consulting, Inc.; Co-leader of the Merger Integration & Carve-outs Practice & a Leader of the Office of the CFO Solutions Practice; Interim Chief Financial Officer at ANGUS Chemicals, AgroFresh, ATW, and Carestream Dental.
StuartB.Gleichenhaus,FTIConsulting,Inc.公司的高级常务董事;合并整合和分拆业务的联合领导&首席财务官解决方案业务办公室的领导;Angus Chemicals、AgroFresh、ATW和Carestream Dental的临时首席财务官。
Stuart B. Gleichenhaus,Senior Managing Director at FTI Consulting, Inc.; Co-leader of the Merger Integration & Carve-outs Practice & a Leader of the Office of the CFO Solutions Practice; Interim Chief Financial Officer at ANGUS Chemicals, AgroFresh, ATW, and Carestream Dental.
Laura J. Phillips

LauraJ.Phillips,谷歌财务合规总监;Vice President,Brown-FormanCorporation公司财务总监;通用汽车公司财务总监助理;上市公司会计监督委员会副总审计师。


Laura J. Phillips,Director of Finance Compliance at Google; Vice President, Corporate Controller of Brown-Forman Corporation; Assistant Corporate Controller of General Motors; Deputy Chief Auditor for the Public Company Accounting Oversight Board.
LauraJ.Phillips,谷歌财务合规总监;Vice President,Brown-FormanCorporation公司财务总监;通用汽车公司财务总监助理;上市公司会计监督委员会副总审计师。
Laura J. Phillips,Director of Finance Compliance at Google; Vice President, Corporate Controller of Brown-Forman Corporation; Assistant Corporate Controller of General Motors; Deputy Chief Auditor for the Public Company Accounting Oversight Board.
Benjamin Wolin

Benjamin Wolin 2002年1月(公司创立之时)他是我们公司的共同创始人,并担任公司的首席执行官,也是公司董事的成员,1999年9月至2001年12月,他担任Beliefnet公司生产与科技的副总裁,其是一家为宗教和精神信息的在线供应商。此前,他担任互动式论坛网页制作公司的董事,该是一家多媒体公司,并在这家互动式公司担任了咨询职位。他担任了几家私人控股公司董事。他获得了Bowdoin学院历史学士学位。


Benjamin Wolin,Former Chief Executive Officer and Co-founder of Everyday Health, Inc.
Benjamin Wolin 2002年1月(公司创立之时)他是我们公司的共同创始人,并担任公司的首席执行官,也是公司董事的成员,1999年9月至2001年12月,他担任Beliefnet公司生产与科技的副总裁,其是一家为宗教和精神信息的在线供应商。此前,他担任互动式论坛网页制作公司的董事,该是一家多媒体公司,并在这家互动式公司担任了咨询职位。他担任了几家私人控股公司董事。他获得了Bowdoin学院历史学士学位。
Benjamin Wolin,Former Chief Executive Officer and Co-founder of Everyday Health, Inc.